C
Kiniksa Pharmaceuticals International, plc KNSA
$31.98 $1.725.68% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 556.29% 148.23% -135.22% 8.39% -126.10%
Total Depreciation and Amortization -16.74% -25.97% -25.93% -33.83% -28.57%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -37.67% -6.37% 138.43% -76.83% 238.95%
Change in Net Operating Assets 83.19% -81.36% 618.48% -49.12% -66.19%
Cash from Operations 443.54% 459.92% 333.99% -113.16% 238.07%
Capital Expenditure -- -17.86% -244.64% 100.00% 100.00%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 92.06% -300.88% 541.34% 48.23% -231.64%
Cash from Investing 91.70% -301.93% 538.38% 48.29% -231.70%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 1,022.91% -20.38% 184.22% 467.35% 96.71%
Repurchase of Common Stock -55.90% -8.14% -120.61% -145.43% -213.37%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 6,110.11% -23.39% 208.20% 1,111.78% -212.66%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 183.49% -179.85% 973.05% -136.02% -230.86%